Graph Therapeutics

Graph Therapeutics is a precision immunology biotech company that uses AI, multi-omics analysis, and patient cell data for treatments.

Health and bioData and analytics

Graph Therapeutics has no funding amount on record yet; its latest known round is Seed (Jun 2026). Recent Funding first saw it on October 2, 2026.

Founders and team

• BS
  Berend Snijder Founder

  source: crunchbase.com
• BV
  Bojan Vilagos Founder

  source: crunchbase.com
• CB
  Christophe Boudesco Founder

  source: crunchbase.com
• GV
  Gregory Vladimer Founder

  source: crunchbase.com
• RS
  Robert Sehlke Founder

  source: crunchbase.com
• YS
  Yannic Severin Founder

  source: crunchbase.com

Raise history

1. June 22, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related ai companies

• GGood Tape$600K · Oct 2, 2026
• 11club AI$2.2M · Oct 1, 2026
• PPredictive AIOct 1, 2026
• JJAOPS$260M · Oct 1, 2026
• EestaieOct 1, 2026
• OOpensOct 1, 2026
• KKeepsake Family HistoryOct 1, 2026
• MMetisJeanOct 1, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/graph-therapeutics.